Related Experiment Videos
Peritoneal dialysis in diabetic patients
1Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea. hblee@seoul.com
Summary
Diabetic nephropathy patients on peritoneal dialysis (PD) may experience better survival than hemodialysis initially. However, PD may accelerate peritoneal membrane damage, potentially worsened by conventional solutions.
Area of Science:
- Nephrology
- Diabetology
- Renal Replacement Therapy
Background:
- Diabetic nephropathy is a primary cause of end-stage renal disease globally.
- While mortality for diabetic patients on dialysis has decreased, it remains higher than for non-diabetics.
- Peritoneal dialysis (PD) shows promise for younger diabetic patients early in their dialysis journey.
Purpose of the Study:
- To evaluate the survival and technique outcomes of diabetic patients undergoing PD compared to hemodialysis.
- To investigate the impact of PD on peritoneal membrane structure and function in diabetic patients.
- To explore potential strategies for mitigating PD-related complications in diabetic nephropathy.
Main Methods:
- Comparative analysis of survival rates between diabetic and non-diabetic patients on PD and hemodialysis.
- Assessment of PD technique survival in diabetic versus non-diabetic populations.
- Examination of peritoneal membrane changes, including fibrosis and permeability, in diabetic patients on PD.
Main Results:
- PD offers comparable or superior survival to hemodialysis for younger diabetic patients in the initial dialysis years.
- PD technique survival is similar between diabetic and non-diabetic patients but inferior to hemodialysis technique survival.
- PD may accelerate peritoneal membrane alterations in diabetic patients, with peritonitis and conventional solutions implicated in technique failure.
Conclusions:
- While PD can be beneficial for younger diabetic patients, its long-term impact on the peritoneal membrane requires careful consideration.
- Conventional PD solutions may contribute to peritoneal membrane damage in diabetic patients.
- Exploring alternative PD solutions, such as nonglucose or low-glucose degradation product solutions, may preserve peritoneal membrane function in long-term PD for both diabetic and non-diabetic individuals.